Baby Girl, Cabilez .
HRN: 25-67-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/08/2025
01/15/2025
IV
35 Mg
OD
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes